Ivabradine

Details

Files

Generic Name:

Ivabradine

Project Status:

Complete

Therapeutic Area:

Heart failure, NYHA class II or III

Manufacturer:

Servier Canada Inc.

Call for patient/clinician input open:

October 11, 2016

Brand Name:

Lancora

Project Line:

Reimbursement Review

Project Number:

SR0506-000

Call for patient/clinician input closed:

November 29, 2016

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Heart failure, NYHA class II or III

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 24, 2017

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : October 11, 2016